How many insider declarations has Ligand Pharmaceuticals Inc filed?

Ligand Pharmaceuticals Inc has filed 2 public insider declarations with SEC (Form 4).

What is Ligand Pharmaceuticals Inc's role?

Ligand Pharmaceuticals Inc's reported role is not specified by the regulator across the filings.

Which companies does Ligand Pharmaceuticals Inc report trades for?

Ligand Pharmaceuticals Inc reports trades for 2 companies, including OmniAb Operations, Inc..

← Executives ★ Sign in to follow

LP

Ligand Pharmaceuticals Inc

·SEC (Form 4)

OmniAb Operations, Inc.Pelthos Therapeutics Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Ligand Pharmaceuticals Inc. Director active across 2 companies, notably OmniAb Operations, Inc.. In total, 2 filings have been recorded. Activity tracked since 1 November 2022. The latest transaction was disclosed on 1 July 2025 (C). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Ligand Pharmaceuticals Inc

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

OmniAb Operations, Inc. (US)Pelthos Therapeutics Inc. (US)

申报2 总计

●

LIGAND PHARMACEUTICALS INC

高管2025年7月1日Pelthos Therapeutics Inc.

US$1500万0SEC ↗

1,500,000 股@ US$10.00Common StockSEC:0000950170-25-093589:0

●